Our findings demonstrated that the anti-histaminic drugs CTZ and LOR may target PI3K/p-Akt/Nrf2 as an underlying mechanism for their ability to treat ulcerative colitis in rats produced by acetic acid. The gene discussed is NFE2L2; the disease is ulcerative colitis.